Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > Peptides And Amino Acids > C225H348N48O68 Tirzepatide Powder CAS 2023788-19-2 Soluble In DMSO

C225H348N48O68 Tirzepatide Powder CAS 2023788-19-2 Soluble In DMSO

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 2023788-19-2

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Aluminum Foil Bag, Drum

Delivery Time: 7-15 days

Payment Terms: T/T, L/C, D/A, Western Union

Supply Ability: TON

Get Best Price
Highlight:

tirzepatide powder CAS 2023788-19-2

,

C225H348N48O68 Tirzepatide Powder

CAS No::
2023788-19-2
Appearance::
White Powder
Molecular Formula::
C225H348N48O68
Molecular Weight::
4813.45
EINECS NO::
200-001-8
MDL NO.::
N/A
CAS No::
2023788-19-2
Appearance::
White Powder
Molecular Formula::
C225H348N48O68
Molecular Weight::
4813.45
EINECS NO::
200-001-8
MDL NO.::
N/A
C225H348N48O68 Tirzepatide Powder CAS 2023788-19-2 Soluble In DMSO

Product Description:

Product Name:Tirzepatide CAS 2023788-19-2

 

Synonyms:

GIPGLP-1;

GipGLP-1 Tirzepatide Ly3298176 Peptide.

 

Chemical & Physical Properties

Appearance:White powder

Assay: NLT98%

Solubility:Soluble in DMSO

 

Application:Tirzepatide has a similar sequence to semaglutide. The lys side chain in the sequence is modified with PEG, which is a functional group of the polypeptide and can increase the water solubility of the sequence.The main physiological function of Tirzepa Chemicalbooktide is a dual agonist of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. It is being developed for the treatment of type 2 diabetes and has entered the clinical stage.

 

If you are interested in our products or have any questions, please feel free to contact us!

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.